A Prospectively Randomized Trial of Low-Dose Leucovorin Plus 5-FU, High-Dose Leucovorin Plus 5-FU, Levamisole Plus 5-FU, or Low-Dose Leucovorin Plus 5-FU Plus Levamisole Following Curative Resection in Selected Patients with Duke's B or C Colon Cancer

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089

DG Haller;PJ Catalano;JS Macdonald;MA O'Rourke;MS Frontiera;DV Jackson;RJ Mayer Journal of Clinical Oncology 23(34):8671-8678

Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089

RJ Green;JP Metlay;K Propert;PJ Catalano;JS Macdonald;RJ Mayer;DG Haller Annals of Internal Medicine 136(4):261-269

Outcomes and toxicity in African-American and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

AD McCollum;PJ Catalano;DG Haller;RJ Mayer;JS Macdonald;AB Benson III;CS Fuchs Journal of the National Cancer Institute 94(15):1160-1167

Outcomes and toxicity in African-American an d caucasian patients receiving adjuvant chemotherapy for colon cancer: a secondary analysis of INT-0089

AD McCollum;PJ Catalano;DG Haller;RJ Mayer;JS Macdonald Proc of the American Society of Clinical Oncology 20:133a(#528)

Colon cancer survival is associated iwth increasing number of lymph nodes removed. a secondary analysis of INT-0089

TE Lo Voyer;ER Sigurdson;AL Hanlon;RJ Mayer;JS Macdonald;PJ Catalano;DG Haller Proc of the American Society of Clinical Oncology 19:239a(#925)

Surveillance for second primary colon cancers after adjuvant chemotherapy: analysis of INT-0089

RJ Green;JP Metlay;K Propert;PJ Catalano;JS Macdonald;RJ Mayer;DG Haller Proc of the American Society of Clinical Oncology 18:237a(#910)

Fluorouracil (FU), leucovorin (LV), and levamisole (LEV) adjuvant therapy for colon cancer: Five-year final report of INT-0089.

DG Haller;PJ Catalano;JS Macdonald;RJ Mayer Proc of the American Society of Clinical Oncology 17:256a(#982)

Thymidylate synthase expression as a predictor for response to 5-fluorouracil-based therapy and survival for patients (pts) with resected colon or advanced colorectal cancer. An ECOG study.

AB Benson,III;PJ Catalano;S Rao;DG Haller;PJ O'Dwyer;CJ Allegra;PG Johnston Proc of the American Society of Clinical Oncology 16:258a(#917)

Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: four year results of INT-0089

DG Haller;PJ Catalano;JS Macdonald;RJ Mayer Proc of the American Society of Clinical Oncology 16:265a(#940)

Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Preliminary results of INT-0089.

DG Haller;PJ Catalano;JS Macdonald;RJ Mayer American Society of Clinical Oncology 15:211(#486)